Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes
← catalyst calendarNCT07565545 · readout ≤ 590 d
Sponsored by SI-BONE, Inc. (industry) · SIBN — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
120estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2026 | estimated | When the study began enrolling |
| Primary completion | Mar 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Sep 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Sacro Iliac Joint Pain
- Sacro-iliac Joints
- Sacroiliac Disorder
- Sacroiliac Joint Dysfunction
- Sacroiliac Joint Disruption
- Degenerative Sacroiliitis
Intervention
- Device: iFuse INTRA Ti Implant System
Primary outcome
what the primary-completion date above is the date OFComposite endpoint of safety and performance
measured 6 months.
Permalink · SIBN's whole pipeline · Catalyst calendar · Every registered study · What changed